在患有喘的儿童中,基线2型生物标志物水平和临床缓解预测因素
Mengmeng Chen1,2, Congcong Li1, Qiuyan Yang3
1Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Frontiers in immunology
|June 12, 2025
概括
血清胆小板层淋巴蛋白 (TSLP) 与患有高Th2喘的儿童的临床缓解有关. 虽然TSLP单独显示了适度的预测价值,但将其与其他标记物结合起来可能会改善喘缓解的评估.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 生物标志物发现发现
背景情况:
- 关于儿童喘在不同疾病阶段的2型生物标志物水平和临床特征的研究有限.
- 了解这些关系对于预测喘预后和缓解至关重要.
研究的目的:
- 调查基线Th2生物标志物水平和儿科喘中的临床表现之间的关联.
- 确定儿童喘患者临床缓解的预测因素.
主要方法:
- 172名儿童 (119名喘患者,53名对照患者) 接受了临床评估,包括肺功能,FeNO,IgE和血液中乙酸氨基细胞.
- 血清生物标志物 (TSLP,IL-4/5/13,TARC,Periostin) 和IgE通过ELISA进行测量.
- 高Th2喘患者被分为急性发作,持久性喘和临床缓解组;用小鼠模型验证TSLP的预测价值.
主要成果:
- 在急性恶化和持续性喘中,血清TSLP水平显著升高.
- 多变量回归确定TSLP作为缓解的独立预测因子 (OR=1.009,P=0.023).
- ROC分析显示TSLP在预测缓解方面具有中度的区分能力 (AUC=0.59),在小鼠缓解模型中观察到正常化.
结论:
- 血清TSLP与Th2-高儿科喘的临床缓解独立相关.
- 虽然TSLP具有中等的独立预测准确性,但包括肺功能和IgE在内的复合生物标志物面板可能会增强缓解评估.
- 这种分层方法可以帮助个性化喘管理和风险分层,需要进一步的纵向验证.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
64
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K


